Active Ingredient(s): Plecanatide
FDA Approved: * January 19, 2017
Pharm Company: * SYNERGY PHARMS
Category: Laxative

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Trulance Overview

Plecanatide (brand name Trulance), is a drug approved in January 2017 by the FDA for the treatment of chronic idiopathic constipation (CIC).[1] Plecanatide is a guanylate cyclase-C agonist. Plecanatide increases intestinal transit and fluid through a buildup of cGMP,.[2][3] See also Linaclotide, another guanylate cyclase-C agonist References ^ "FDA approves Trulance for Chronic Idiopathic Constipation". U.S. Food and Drug Administration. Retrieved 20 January 2017. ^ "TRULANCE p...

Read more Trulance Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Trulance Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 3mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Plecanatide or a similar ingredient: (1 result)